Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

医学 脂肪性肝炎 氧化应激 药理学 脂肪肝 肝硬化 肝细胞癌 血管生成 肝再生 肝细胞 癌症研究 肝癌 癌症 肝损伤 内科学 再生(生物学) 化学 生物 体外 生物化学 疾病 细胞生物学
作者
János Fehér,Gabriella Lengyel
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science]
卷期号:13 (1): 210-217 被引量:213
标识
DOI:10.2174/138920112798868818
摘要

In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the hepatic cell injury in these patients. The silymarin exerts membrane-stabilizing and antioxidant activity, it promotes hepatocyte regeneration; furthermore it reduces the inflammatory reaction, and inhibits the fibrogenesis in the liver. These results have been established by experimental and clinical trials. According to open studies the long-term administration of silymarin significantly increased survival time of patients with alcohol induced liver cirrhosis. Based on the results of studies using methods of molecular biology, silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Furthermore, it exerts an anti-atherosclerotic effect, and suppresses tumor necrosis factor-alpha-induced protein production and mRNA expression due to adhesion molecules. The chemopreventive effect of silymarin on HCC has been established in several studies using in vitro and in vivo methods; it can exert a beneficial effect on the balance of cell survival and apoptosis by interfering cytokines. In addition to this, anti-inflammatory activity and inhibitory effect of silymarin on the development of metastases have also been detected. In some neoplastic diseases silymarin can be administered as adjuvant therapy as well. Keywords: Cancer prevention, chronic liver diseases, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, silymarin, steatohepatitis, oxidative stress, Liver cirrhosis, membrane-stabilizing, insulin resistance, metastases, adjuvant therapy, hepatobiliary diseases

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LIUJIE完成签到,获得积分10
1秒前
WJY完成签到,获得积分10
1秒前
轩辕剑身完成签到,获得积分0
2秒前
1101592875完成签到,获得积分10
3秒前
木雨亦潇潇完成签到,获得积分10
3秒前
刘亮亮完成签到,获得积分10
4秒前
www完成签到 ,获得积分0
4秒前
QS完成签到,获得积分10
4秒前
Lucas应助WJY采纳,获得10
6秒前
6秒前
Panini完成签到 ,获得积分10
7秒前
zhang完成签到 ,获得积分10
8秒前
她的城完成签到,获得积分0
9秒前
韩祖完成签到 ,获得积分10
9秒前
科研通AI6应助垣味栗子酱采纳,获得10
10秒前
Ellalala完成签到 ,获得积分10
10秒前
量子星尘发布了新的文献求助10
12秒前
草木发布了新的文献求助10
14秒前
14秒前
Much完成签到 ,获得积分10
17秒前
凡华完成签到 ,获得积分10
19秒前
奋进中的科研小菜鸟完成签到,获得积分10
20秒前
23秒前
星空完成签到 ,获得积分10
23秒前
量子星尘发布了新的文献求助10
28秒前
巧克力完成签到 ,获得积分10
28秒前
HU完成签到,获得积分10
29秒前
垣味栗子酱完成签到,获得积分20
30秒前
胖胖玩啊玩完成签到 ,获得积分10
32秒前
Tammy完成签到,获得积分10
32秒前
阿伟完成签到,获得积分10
34秒前
无极微光应助白华苍松采纳,获得20
35秒前
酷酷的安柏完成签到 ,获得积分10
36秒前
37秒前
lovekobe完成签到 ,获得积分10
37秒前
鲁卓林完成签到,获得积分10
37秒前
甜美傲蕾完成签到,获得积分10
38秒前
38秒前
yunt完成签到 ,获得积分10
40秒前
小高完成签到 ,获得积分10
41秒前
高分求助中
Encyclopedia of Immunobiology Second Edition 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
List of 1,091 Public Pension Profiles by Region 1621
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] | NHBS Field Guides & Natural History 1500
The Victim–Offender Overlap During the Global Pandemic: A Comparative Study Across Western and Non-Western Countries 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
Brittle fracture in welded ships 1000
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5584850
求助须知:如何正确求助?哪些是违规求助? 4668735
关于积分的说明 14771737
捐赠科研通 4616005
什么是DOI,文献DOI怎么找? 2530253
邀请新用户注册赠送积分活动 1499111
关于科研通互助平台的介绍 1467590